Skip to content
Home/Companies/Pharma/Mirum Pharmaceuticals

Mirum Pharmaceuticals

Pharma·United States·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals is an American Pharma company, currently owned by Novo Holdings since 2018.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Growth Investments · 1999 · Growth

Key facts

HQUnited States
SectorPharma
StatusActive

More from Novo Holdings Growth Investments

Other portfolio companies in the same fund.

Surya Hospitals
Active
HealthcareIndia· 2026
Phasecraft
Phasecraft
Active
Deep TechUK· 2025
AvenCell
Active
BiotechUS· 2024
Cleveland Diagnostics
Active
MedTechUS· 2024
Convergent
Active
BiotechUS· 2024
Medi Assist
Active
HealthTechIndia· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals is currently owned by Novo Holdings, through Novo Holdings Growth Investments, since 2018.

When did Novo Holdings acquire Mirum Pharmaceuticals?

Novo Holdings acquired Mirum Pharmaceuticals in 2018.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue